ArticleClinical lung cancer2024

RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer.

Amanda Reyes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.